Eyal Flom
Direktor/Vorstandsmitglied bei INNOCAN PHARMA CORPORATION
Vermögen: 475 055 $ am 30.04.2024
Aktive Positionen von Eyal Flom
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INNOCAN PHARMA CORPORATION | Direktor/Vorstandsmitglied | 25.09.2019 | - |
| Unternehmenssekretär | 22.01.2020 | - | |
| REVIUM RECOVERY INC. | Direktor/Vorstandsmitglied | - | - |
| Israeli Pharmaceutical Association | General Counsel | 01.04.1995 | - |
NurExone Biologic Ltd.
 NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Eyal Flom
Ehemalige bekannte Positionen von Eyal Flom
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NUREXONE BIOLOGIC INC. | Direktor/Vorstandsmitglied | 15.06.2022 | 08.05.2023 |
Ausbildung von Eyal Flom
| University of Derby | Masters Business Admin |
| Tel-Aviv University | Graduate Degree |
Statistik
International
| Israel | 6 |
| Vereinigtes Königreich | 2 |
| Kanada | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Secretary | 1 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| REVIUM RECOVERY INC. | Distribution Services |
| INNOCAN PHARMA CORPORATION | Health Technology |
| NUREXONE BIOLOGIC INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Israeli Pharmaceutical Association | |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Health Technology |
